Royalty Pharma plc Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Royalty Pharma plc quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Royalty Pharma plc Return On Equity for the quarter ending September 30, 2024 was 11.5 %, a 502% increase year-over-year.
  • Royalty Pharma plc annual Return On Equity for 2023 was 11.6 %, a 2630% increase from 2022.
  • Royalty Pharma plc annual Return On Equity for 2022 was 0.42 %, a 93% decline from 2021.
  • Royalty Pharma plc annual Return On Equity for 2021 was 6.06 %, a 43.6% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 11.6 +11.1 +2630% Jan 1, 2023 Dec 31, 2023
2022 0.42 -5.64 -93% Jan 1, 2022 Dec 31, 2022
2021 6.06 -4.69 -43.6% Jan 1, 2021 Dec 31, 2021
2020 10.8 -35.3 -76.6% Jan 1, 2020 Dec 31, 2020
2019 46.1 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.